National Cancer Institute; Notice of Closed Meetings, 61489-61490 [2024-16813]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 147 / Wednesday, July 31, 2024 / Notices
security for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page:
www.drugabuse.gov/NACDA/
NACDAHome.html, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: July 25, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–16814 Filed 7–30–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
lotter on DSK11XQN23PROD with NOTICES1
National Institute on Alcohol Abuse
and Alcoholism; Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council on Alcohol Abuse and
Alcoholism.
This will be a hybrid meeting held inperson and virtually and will be open to
the public as indicated below.
Individuals who plan to attend inperson or view the virtual meeting and
need special assistance or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
can be accessed from the NIH Videocast
at the following link: https://
videocast.nih.gov/.
A portion of this meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Sep<11>2014
17:29 Jul 30, 2024
Jkt 262001
Name of Committee: National Advisory
Council on Alcohol Abuse and Alcoholism.
Date: September 12, 2024.
Closed: 10:00 a.m. to 10:50 a.m.
Agenda: To review and evaluate grant
applications.
Open: 11:00 a.m. to 3:30 p.m.
Agenda: Presentations and other business
of the Council.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, Conference Rooms A, B & C,
6700B Rockledge Drive, Bethesda, MD 20817
(Hybrid Meeting).
Contact Person: Philippe Marmillot, Ph.D.,
Director, Office of Extramural Activities,
National Institute on Alcohol Abuse and
Alcoholism, National Institutes of Health,
6700B Rockledge Drive, Room 2118,
Bethesda, MD 20892, (301) 443–2861,
marmillotp@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.niaaa.nih.gov/AboutNIAAA/
AdvisoryCouncil/Pages/default.aspx, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.273, Alcohol Research
Programs, National Institutes of Health, HHS)
Dated: July 25, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–16815 Filed 7–30–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
PO 00000
Frm 00093
Fmt 4703
Sfmt 4703
61489
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute, Special Emphasis Panel; SEP–1:
NCI Clinical and Translational Cancer
Research.
Date: September 19, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W108, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Clifford W. Schweinfest,
Ph.D., Scientific Review Officer, Special
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W108,
Rockville, Maryland 20850, 240–276–6343,
schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer
Institute, Special Emphasis Panel; SEP–4:
NCI Clinical and Translational Cancer
Research.
Date: September 24, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W264, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Ombretta Salvucci, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W264, Rockville,
Maryland 20850, 240–276–7286, salvucco@
mail.nih.gov.
Name of Committee: National Cancer
Institute, Special Emphasis Panel; Projects in
Physical Sciences and Oncology (U01)
Review.
Date: September 25, 2024.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W640, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Saejeong J. Kim, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W640, Rockville,
Maryland 20850, 240–276–7684,
saejeong.kim@nih.gov.
Name of Committee: National Cancer
Institute, Special Emphasis Panel; Clinical
Trials Planning Program.
Date: October 4, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
E:\FR\FM\31JYN1.SGM
31JYN1
lotter on DSK11XQN23PROD with NOTICES1
61490
Federal Register / Vol. 89, No. 147 / Wednesday, July 31, 2024 / Notices
7W106, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Eduardo Emilio Chufan,
Ph.D., Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W106, Rockville, Maryland
20850, 240–276–7975, chufanee@
mail.nih.gov.
Name of Committee: National Cancer
Institute, Special Emphasis Panel; SEP–9:
NCI Clinical and Translational Cancer
Research.
Date: October 9, 2024.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W640, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Saejeong J. Kim, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W640, Rockville,
Maryland 20850, 240–276–7684,
saejeong.kim@nih.gov.
Name of Committee: National Cancer
Institute, Special Emphasis Panel; SEP–12:
NCI Clinical and Translational Cancer
Research.
Date: October 16, 2024.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W246, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Jun Fang, Ph.D., Scientific
Review Officer, Research Technology and
Contract Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W246, Rockville, Maryland 20850,
240–276–5460, jfang@mail.nih.gov.
Name of Committee: National Cancer
Institute, Special Emphasis Panel; SEP–8:
NCI Clinical and Translational Cancer
Research.
Date: October 29–30, 2024.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W110, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Priya Srinivasan, Ph.D.,
Scientific Review Officer, Resource and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W110, Rockville, Maryland 20850,
240–276–5619, priya.srinivasan@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
VerDate Sep<11>2014
17:29 Jul 30, 2024
Jkt 262001
Cancer Control, National Institutes of Health,
HHS)
Date: July 19, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–16813 Filed 7–30–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer
Advisory Board.
This will be a hybrid meeting held inperson and virtually and will be open to
the public as indicated below.
Individuals who plan to attend inperson or view the virtual meeting and
need special assistance or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
can be accessed from the NIH Videocast
at the following link: https://
videocast.nih.gov/.
A portion of the meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Advisory Board.
Date: September 3, 2024.
Open: 6:00 p.m. to 9:00 p.m.
Agenda: National Cancer Advisory Board
Subcommittee Meetings.
Place: Gaithersburg Marriott
Washingtonian Center, Room—TBD, 9751
Washington Boulevard, Gaithersburg, MD
20878.
Contact Person: Paulette S. Gray, Ph.D.,
Director, Division of Extramural Activities,
National Cancer Institute—Shady Grove,
National Institutes of Health, 9609 Medical
Center Drive, 7th Floor, Room 7W444,
Bethesda, MD 20892, 240–276–6340, grayp@
mail.nih.gov.
Name of Committee: National Cancer
Advisory Board.
Date: September 4, 2024.
Open: 9:00 a.m. to 3:50 p.m.
Agenda: Director and Program Reports and
Presentations. Business of the Board.
PO 00000
Frm 00094
Fmt 4703
Sfmt 9990
Closed: 3:50 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute—Shady
Grove, 9609 Medical Center Drive, Room
TE406 & 408, Rockville, MD 20850 (Hybrid
Meeting).
Contact Person: Paulette S. Gray, Ph.D.,
Director, Division of Extramural Activities,
National Cancer Institute—Shady Grove,
National Institutes of Health, 9609 Medical
Center Drive, 7th Floor, Room 7W444,
Bethesda, MD 20892, 240–276–6340, grayp@
mail.nih.gov.
Name of Committee: National Cancer
Advisory Board.
Date: September 5, 2024.
Open: 9:00 a.m. to 12:00 p.m.
Agenda: Program Reports and
Presentations. Business of the Board.
Place: National Cancer Institute—Shady
Grove, 9609 Medical Center Drive, Room
TE406 & 408, Rockville, MD 20850 (Hybrid
Meeting).
Contact Person: Paulette S. Gray, Ph.D.,
Director, Division of Extramural Activities,
National Cancer Institute—Shady Grove,
National Institutes of Health, 9609 Medical
Center Drive, 7th Floor, Room 7W444,
Bethesda, MD 20892, 240–276–6340, grayp@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NCI—Shady Grove campus. All
visitors will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: NCAB: https://
deainfo.nci.nih.gov/advisory/ncab/ncab.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 3.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: July 25, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–16816 Filed 7–30–24; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\31JYN1.SGM
31JYN1
]]>Agencies
[Federal Register Volume 89, Number 147 (Wednesday, July 31, 2024)]
[Notices]
[Pages 61489-61490]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-16813]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute, Special Emphasis
Panel; SEP-1: NCI Clinical and Translational Cancer Research.
Date: September 19, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W108, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Clifford W. Schweinfest, Ph.D., Scientific
Review Officer, Special Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W108, Rockville, Maryland 20850, 240-276-6343,
[email protected].
Name of Committee: National Cancer Institute, Special Emphasis
Panel; SEP-4: NCI Clinical and Translational Cancer Research.
Date: September 24, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W264, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Ombretta Salvucci, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W264, Rockville, Maryland 20850, 240-276-7286,
[email protected].
Name of Committee: National Cancer Institute, Special Emphasis
Panel; Projects in Physical Sciences and Oncology (U01) Review.
Date: September 25, 2024.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W640, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Saejeong J. Kim, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W640, Rockville, Maryland 20850, 240-276-7684,
[email protected].
Name of Committee: National Cancer Institute, Special Emphasis
Panel; Clinical Trials Planning Program.
Date: October 4, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room
[[Page 61490]]
7W106, Rockville, Maryland 20850 (Virtual Meeting).
Contact Person: Eduardo Emilio Chufan, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W106, Rockville, Maryland 20850, 240-276-7975,
[email protected].
Name of Committee: National Cancer Institute, Special Emphasis
Panel; SEP-9: NCI Clinical and Translational Cancer Research.
Date: October 9, 2024.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W640, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Saejeong J. Kim, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W640, Rockville, Maryland 20850, 240-276-7684,
[email protected].
Name of Committee: National Cancer Institute, Special Emphasis
Panel; SEP-12: NCI Clinical and Translational Cancer Research.
Date: October 16, 2024.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850, 240-276-5460,
[email protected].
Name of Committee: National Cancer Institute, Special Emphasis
Panel; SEP-8: NCI Clinical and Translational Cancer Research.
Date: October 29-30, 2024.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W110, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Priya Srinivasan, Ph.D., Scientific Review
Officer, Resource and Training Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W110, Rockville, Maryland 20850, 240-276-5619,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Date: July 19, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-16813 Filed 7-30-24; 8:45 am]
BILLING CODE 4140-01-P
